Charm Care (6062) Fundamentals 2026 — P/E 12.2x, Revenue Analysis | SniperIQ
Charm Care (6062) is a JP-listed Healthcare company in Medical - Care Facilities with a market capitalization of ¥44.5B, trading at ¥1362.00 on the JPX. This SniperIQ fundamentals page covers Charm Care's valuation (P/E 12.2x, P/B 2.1x), profitability (net margin 7.3%), revenue (¥46.7B in FY2024), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Charm Care's market cap?
Charm Care (6062) has a market capitalization of approximately ¥44.5B, trading at ¥1362.00 on the JPX. Market cap moves with the live share price.
What is Charm Care's P/E ratio?
Charm Care's trailing twelve-month P/E ratio is 12.2x, with a price-to-book (P/B) of 2.1x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Charm Care?
Charm Care runs a net profit margin of 7.3%, a gross margin of 17.1%, and an operating margin of 9.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Charm Care generate?
Charm Care reported revenue of ¥46.7B for fiscal year 2024, with net income of ¥2.9B and earnings per share (EPS) of 89.88. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Charm Care pay a dividend?
Charm Care offers a trailing dividend yield of about 3.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Charm Care financially healthy?
Charm Care carries a debt-to-equity ratio of 0.66x and a current ratio of 0.87x, with a market beta of 0.78. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Charm Care a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Charm Care (6062) the key facts are: market cap ¥44.5B, P/E 12.2x, revenue ¥46.7B, 52-week range 1029-1457. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Charm Care's full fundamentals live
Get Charm Care's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.